Two million patients have received the CYPHER sirolimus-eluting coronary stent since its market introduction in Europe in April 2002, a first-time milestone for any company in the drug- eluting stent industry. The CYPHER stent is the world leading drug-eluting stent for the treatment of coronary artery disease and helped redefine innovation in interventional cardiology. Yahoo News (http://biz.yahoo.com/prnews/060426/nyw101.html?.v=48)